The world’s first adhesive with a smart and switchable function to showcase new clinical data and innovations at the 2018 5th Annual Innovations in Wound Healing meeting
Key West, FL (December 7, 2018) Global Biomedical Technologies (GBT) has expanded its portfolio of research innovations beyond its first commercial product launch of Comfort Release® acute care/first aid wound bandages and tapes with a 2019 entry into the advanced wound care market space. GBT featured this novel adhesive technology along with acute and advanced product samples at the 5th Annual Innovations in Wound Healing meeting held at the Casa Marina Key West Hotel and Convention Center in Key West, FL, December 7, 2018.
In addition to introducing currently available Comfort Release® acute care and first aid bandages and tapes at the meeting, GBT provided a preview of its entry into advanced wound care by sharing samples of its new portfolio of foam border and transparent adhesive dressings, and IV catheter and tubing securement dressings within its exhibit hall booth. The new portfolio is scheduled to launch in the US during the first quarter of 2019. GBT also featured a clinical poster presentation at the meeting titled, “The Benefits of Oligomeric Switch Adhesives in Advancing Wound Care” as the breakthrough Peel Strength and MVTR data will support both the acute and advanced wound product portfolios.
“Removal of wound coverings remains a significant challenge for the healthcare community,” said Dr. Howard Rosing, President of GBT. “Each year, there are 1.5 million injuries associated with adhesive bandage removal in the U.S. alone.” Comfort Release® acute and advanced wound management products are important new options for clinicians and caregivers working to manage wounds of all kinds. Leveraging GBT’s 8 years of developing the technology, which led to the achievement of 7 patents to support this smart switchable adhesive platform, we recognize that there is no single solution in wound care, and we continue to expand our portfolio and deliver on our mission of commercializing new innovations in adhesives which will lead to the next generation of options to manage, treat, and deliver appropriate care at the skin surface level”
A recent article published in Wound Source by Laurie Swezey, RN, CWOCN titled, “How to Decrease Pain Associated with Wound Dressing Changes,” demonstrates the potential for the Comfort Release® Smart Switchable Pain – Free adhesive technology as the number one remedy cited is to choose the correct dressing that won’t adhere to the wound bed and can be easily removed.
“We are dedicated to innovation in smart adhesive science to improve clinical outcomes and support healthcare providers,” said Dr. Rosing. “We are excited to finally showcase the translation of our scientific developments with proven clinical results to be achieved in the marketplace.”
About Global Biomedical Technologies
Global Biomedical Technologies is based in Naples, FL and is a commercial consortium comprised of leading academic medical researchers, and governed by a board of directors who are leading experts in adhesive innovations, patient care, and downstream market strategy. For more information, visit www.comfortrelease.com.
Media Contact: TJ Douglas – 470.636.4410 – tdouglas@comfortrelease.com
